Search Results - "Sansom, O J"
-
1
Microenvironmental cues in cancer stemness
Published in Nature cell biology (01-10-2018)“…Intra-tumour heterogeneity manifests both at the level of mutational burden, and at a functional level within genetically homogenous populations. A new…”
Get full text
Journal Article -
2
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells
Published in Nature communications (19-03-2018)“…Many epithelial stem cell populations follow a pattern of stochastic stem cell divisions called 'neutral drift'. It is hypothesised that neutral competition…”
Get full text
Journal Article -
3
Exploiting inflammation for therapeutic gain in pancreatic cancer
Published in British journal of cancer (19-03-2013)“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated with <5% 5-year survival, in which standard chemotherapeutics have limited…”
Get full text
Journal Article -
4
Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptors
Published in Nature communications (23-01-2020)“…The number of patients diagnosed with chronic bile duct disease is increasing and in most cases these diseases result in chronic ductular scarring,…”
Get full text
Journal Article -
5
Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine
Published in Oncogene (29-04-2010)“…The adenomatous polyposis coli ( APC ) gene encodes APC tumour suppressor protein, germline mutation of which causes familial adenomatous polyposis, an…”
Get full text
Journal Article -
6
Wnt signalling and its role in stem cell-driven intestinal regeneration and hyperplasia
Published in Acta Physiologica (01-01-2012)“…Adult stem cells are crucial for normal tissue homeostasis and regeneration upon damage. Deregulated stem cell proliferation and/or differentiation have been…”
Get full text
Journal Article Conference Proceeding -
7
A RAC-GEF network critical for early intestinal tumourigenesis
Published in Nature communications (04-01-2021)“…RAC1 activity is critical for intestinal homeostasis, and is required for hyperproliferation driven by loss of the tumour suppressor gene Apc in the murine…”
Get full text
Journal Article -
8
NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression
Published in British journal of cancer (23-10-2012)“…Background: Cell line models suggest that activation of NF κ B is associated with progression of prostate cancer. This pathway may be a therapeutic target if…”
Get full text
Journal Article -
9
Functions of TAp63 and p53 in restraining the development of metastatic cancer
Published in Oncogene (19-06-2014)“…Many tumours harbour mutations in the p53 tumour-suppressor gene that result in the expression of a mutant p53 protein. This mutant p53 protein has, in most…”
Get full text
Journal Article -
10
β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation
Published in Oncogene (13-01-2011)“…Although deregulation of the Wnt signalling pathway has been implicated in urothelial cell carcinoma (UCC), the functional significance is unknown. To test its…”
Get full text
Journal Article -
11
Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
Published in Cell death and differentiation (28-02-2014)Get full text
Journal Article -
12
Absolute requirement for STAT3 function in small-intestine crypt stem cell survival
Published in Cell death and differentiation (03-06-2011)Get full text
Journal Article -
13
Stem vs non-stem cell origin of colorectal cancer
Published in British journal of cancer (30-06-2015)“…Colorectal cancer (CRC) is one of the most common cancers in the western world and is characterised by deregulation of the Wnt signalling pathway. Mutation of…”
Get full text
Journal Article -
14
Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol
Published in Oncogene (09-12-2010)“…Mutations in the adenomatous polyposis coli (APC) tumour suppressor are the key initiating event of colorectal cancer. Although the control of WNT signalling…”
Get full text
Journal Article -
15
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
Published in Oncogene (01-12-2018)“…The life expectancy for pancreatic cancer patients has seen no substantial changes in the last 40 years as very few and mostly just palliative treatments are…”
Get full text
Journal Article -
16
Calcium signalling links MYC to NUAK1
Published in Oncogene (22-02-2018)“…NUAK1 is a member of the AMPK-related family of kinases. Recent evidence suggests that NUAK1 is an important regulator of cell adhesion and migration, cellular…”
Get full text
Journal Article -
17
53BP1 deficiency in intestinal enterocytes does not alter the immediate response to ionizing radiation, but leads to increased nuclear area consistent with polyploidy
Published in Oncogene (20-09-2007)“…The p53-binding protein 53BP1 has been implicated in the DNA damage response and genomic instability. Previous reports have highlighted these roles in vivo in…”
Get full text
Journal Article -
18
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
Published in Oncogene (07-03-2013)“…Tumour-derived mutant p53 proteins promote invasion, in part, by enhancing Rab coupling protein (RCP)-dependent receptor recycling. Here we identified MET as…”
Get full text
Journal Article -
19
Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
Published in Cell death and differentiation (01-06-2014)“…Recent studies have suggested that C-MYC may be an excellent therapeutic cancer target and a number of new agents targeting C-MYC are in preclinical…”
Get full text
Journal Article -
20
Absolute requirement for STAT3 function in small-intestine crypt stem cell survival
Published in Cell death and differentiation (01-12-2011)“…The transcription factor signal transducer and activator of transcription 3 (STAT3) is frequently activated in human cancers. Interestingly, STAT3 also…”
Get full text
Journal Article